Cardioverting device with stored energy selecting means and discharge initiating means, and related method

• US 4,316,472 A
• Filed: 08/09/1979
• Issued: 02/23/1982
• Est. Priority Date: 04/25/1974
• Status: Expired due to Term

• Current Assignee: Haschka-Jones Joint Venture, Mirowski Family Ventures LLC
• Original Assignee: Mieczyslaw Mirowski
• Inventors: Mower, Morton M., Langer, Alois A., Mirowski, Mieczyslaw
• Primary Examiner(s): Kamm, William E.
• Application Number:
  US06/065,228
• Time in Patent Office: 929 Days
• Field of Search: 128/419 D, 128/419 PG, 128/419 PT
• US Class Current: 607/9
• CPC Class Codes: A61N 1/372 Arrangements in connection with the implantation of stimulators
• CPC Class Codes: A61N 1/37247 User interfaces, e.g. input or presentation means
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

An externally controlled implantable electronic device for delivering a cardioverting pulse of energy to the atrium of an ailing heart. In one embodiment, the device is particularly suited for use when the patient visits the office of his physician, and contemplates the transmission of both information and powering energy through the skin of the patient. In another embodiment, the device can be readily operated at home, by the patient, and without the intervention of the physician. Here, the source of energy is permanently implanted.

Claims

1. In a cardioverting device, comprising:

storage means for storing energy to convert an abnormal cardiac rhythm to normal sinus rhythm,

delivery electrode means for discharging the stored energy into the heart of a wearer of the device, and

switch means for controlling the discharge of the stored energy into the heart of the wearer;

said device further comprising;

charging means for deliverying to said storage means said energy to convert said abnormal cardiac rhythm,

determining means for determining when the stored energy has reached a predetermined magnitude for converting said abnormal cardiac rhythm, and

initiating means for initiating the discharge of converting energy into the heart of the wearer after the stored energy has reached said predetermined magnitude;

the improvement wherein said device is an implantable externally programmable cardioverting device, and includes receiving means for receiving commands from external to the skin of the wearer of the device, said programming commands designating a predetermined magnitude of stored energy for converting said abnormal cardiac rhythm, said device also including selecting means responsive to said programming commands received by said receiving means for selecting said predetermined magnitude, from among a plurality of selectable magnitudes, of stored energy, for converting said abnormal cardiac rhythm.

2. In the device recited in claim 1, further comprising test mode means for testing the discharge of said selected predetermined magnitude of stored energy.

3. In the device recited in claim 2, said test mode means comprising:

a test load, and test switch means for controlling the discharge of said selected predetermined magnitude of stored energy selectively into said test load or into the heart of the wearer;

said device further comprising mode control means for controlling the operation of said test switch means.

4. Iin the device recited in claim 3, wherein said mode control means is external to the skin of the wearer.

5. In the device as recited in claim 2, said test mode means comprising:

a test load, and test switch means for controlling the discharge of said selected predetermined magnitude of stored energy selectively into said test load or into the heart of the wearer.

6. In the device of claim 1, wherein said receiver means receives power signals generated from external to the skin of the wearer;

said device including utilizing means for utilizing said power signals as electrical power necessary for the operation of the device.

7. In the device of claim 6, wherein a single channel is utilized for delivering said control signals and said power signals to said receiver means.

8. In the device of claim 1, further comprising:

gating means for receiving a gating signal transmitted external to the skin of the wearer, and responsive thereto for gating said charging means "on"; and

said gating means gating said charging means "off" upon said storage means storing said selected predetermined magnitude of stored energy.

9. In the device of claim 1, said receiver means comprising a transformer.

10. In a cardioverting system including a cardioverting device as recited in claim 1, said device comprising:

additional switch means operable from external to the skin of the wearer for enabling said charging means to deliver the energy to convert said abnormal cardiac rhythm to the storage means;

said system comprising a portable triggering means operable from external to the skin of the wearer, upon the sensing of a condition requiring conversion, for transmitting control commands through the skin of the wearer for operating said additional switch means of said device.

11. In the system of claim 10, further comprising test mode means for testing the delivery of said selected predetermined magnitude of stored energy.

12. In the system of claim 11, said test mode means comprising:

a test load, and test switch means for controlling the delivery of said selected predetermined magnitude of stored energy selectively into said test load or into the heart of the patient;

said device further comprising mode control means for controlling the operation of said test switch means.

13. In a system including a device as recited in claim 1, said system comprising:

monitoring means for monitoring the cardiac condition of the wearer to sense an abnormal cardiac rhythm, and actuating means for issuing said predetermined command signal and transmitting the same through the skin of the wearer to said receiving means, said actuating means being actuated upon the sensing of said abnormal cardiac rhythm by said monitoring means.

14. In the system of claim 13, further comprising test mode means for testing the discharge of said selected predetermined magnitude of stored energy.

15. In the system of claim 14, said test mode means comprising:

a test load, and test switch means for controlling the discharge of said selected predetermined magnitude of stored energy selectively into said test load or into the heart of the wearer;

said device further comprising mode control means for controlling the operation of said test switch means.

16. A method for electrically cardioverting a heart, the method comprising the steps of:

implanting an electronic package beneath the skin of a wearer, said electronic package including a storage element for storing electrical energy to convert an abnormal cardiac rhythm to normal sinus rhythm, delivery electrodes for discharging said stored energy into the heart of the wearer, a receiver for receiving commands from external to the skin of the wearer, and discharge control means responsive to said commands received by said receiver means for initiating the discharge of said stored energy into the heart of the wearer;

sensing an abnormal cardiac rhythm while the wearer is conscious, wherein cardioversion is required; and

delivering, upon such sensing, a command from external to the skin of the wearer to the receiver, said implanted electronic package being responsive thereto for electrically cardioverting the heart by discharging said stored energy through said delivery electrodes into the heart of the wearer.

17. The method of claim 16, wherein said delivery step includes delivering control information from external to the skin of the wearer to the receiver, said control information designating a selected magnitude of stored energy to be discharged through said delivery electrodes into the heart of the wearer.

18. A method for electrically cardioverting a heart, the method comprising the steps of:

implanting an electronic package beneath the skin of a wearer, said electronic package including a storage element for storing electrical energy to convert an abnormal cardiac rhythm to normal sinus rhythm, delivery electrodes for discharging said stored energy into the heart of the wearer, a receiver for receiving control information from external to the skin of the wearer, said control information designating a selected magnitude of energy to be discharged through said delivery electrodes into the heart of the wearer, and charge control means responsive to said control information for storing said selected magnitude of stored energy in said storage element;

sensing an abnormal cardiac rhythm, wherein cardioversion is required;

delivering said control information through the skin of the wearer to cause the storage element to store said selected magnitude of energy; and

electrically cardioverting the heart by discharging said selected magnitude of stored energy through said delivery electrodes into the heart of the wearer.